Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/181949
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bayarri Ferrer, Bernardí | - |
dc.contributor.author | Cruz Alcalde, Alberto | - |
dc.contributor.author | López Vinent, Núria | - |
dc.contributor.author | Micó, María M. | - |
dc.contributor.author | Sans Mazón, Carme | - |
dc.date.accessioned | 2021-12-22T17:33:41Z | - |
dc.date.available | 2023-03-13T06:10:22Z | - |
dc.date.issued | 2021-03-13 | - |
dc.identifier.issn | 0304-3894 | - |
dc.identifier.uri | http://hdl.handle.net/2445/181949 | - |
dc.description.abstract | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has challenged societies around the globe. Technologies based on ozone, a powerful oxidant, have been evaluated to inactivate this virus in aerosols and fomites. However, the high data diversity hinders the possibility of establishing a common ground for determining best practices for the use of these technologies. Furthermore, there is a lack of consensus regarding which are the main mechanisms of ozone virus inactivation. This critical review examined the most relevant information available regarding ozone application in gas-phase for different viruses inactivation (including recent publications dealing with SARS-CoV-2), and pointed towards envelope alteration as the main reaction pathway for enveloped viruses, such as is the case of SARS-CoV-2. It could also be concluded that gaseous ozone can be indeed an effective disinfectant, successfully inactivating viruses such us influenza A H1N1, MERS-CoV, SARS-CoV-1 or even SARS-CoV-2 in aerosols or fomites. In reviewed works, low ozone exposures, just around 0.1-0.4 mg L-1 min, achieve about 4 log10 of inactivation in aerosols, while exposures between 1 and 4 mg L-1 min may be needed to guarantee an inactivation of 3-4 log10 in different fomites. Although further studies are required, ozone is an effective candidate to be used against SARS-CoV-2 or other viruses in surfaces and indoor locations. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier B.V. | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1016/j.jhazmat.2021.125658 | - |
dc.relation.ispartof | Journal of Hazardous Materials, 2021, vol. 415, num. 125658 | - |
dc.relation.uri | https://doi.org/10.1016/j.jhazmat.2021.125658 | - |
dc.rights | cc-by-nc-nd (c) Bayarri et al, 2021 | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.source | Articles publicats en revistes (Enginyeria Química i Química Analítica) | - |
dc.subject.classification | COVID-19 | - |
dc.subject.classification | SARS-CoV-2 | - |
dc.subject.classification | Ozonització | - |
dc.subject.classification | Aerosols | - |
dc.subject.other | COVID-19 | - |
dc.subject.other | SARS-CoV-2 | - |
dc.subject.other | Ozonization | - |
dc.subject.other | Aerosols | - |
dc.title | Can ozone inactivate SARS-CoV-2? A review of mechanisms and performance on viruses | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 711044 | - |
dc.date.updated | 2021-12-22T17:33:41Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Enginyeria Química i Química Analítica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
711044.pdf | 1.78 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License